{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "21947506",
  "DateCompleted": {
    "Year": "2012",
    "Month": "02",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2014",
    "Month": "11",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2011",
        "Month": "09",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00705-011-1114-9"
    ],
    "Journal": {
      "ISSN": "1432-8798",
      "JournalIssue": {
        "Volume": "156",
        "Issue": "12",
        "PubDate": {
          "Year": "2011",
          "Month": "Dec"
        }
      },
      "Title": "Archives of virology",
      "ISOAbbreviation": "Arch Virol"
    },
    "ArticleTitle": "Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine.",
    "Pagination": {
      "StartPage": "2181",
      "EndPage": "2186",
      "MedlinePgn": "2181-6"
    },
    "Abstract": {
      "AbstractText": [
        "Human urine has been poorly investigated with regard to infection with human immunodeficiency virus (HIV). Here, we have studied the anti-infective functional properties of human urine against HIV. The effect of fresh urine pools on CCR5- and CXCR4-tropic HIV-1 was evaluated by using four in vitro mucosal models: reduction of infectivity of urine-treated HIV-1 particles, HIV-1 attachment to immature monocyte-derived dendritic cells (iMDDC), transfer of HIV-1 particles from iMDDC to autologous CD4 T cells, and HIV-1 transcytosis through epithelial cells. Human urine partially disrupted both CCR5- and CXCR4-tropic HIV-1 particles, moderately decreased the adsorption of HIV-1 on dendritic cells, and partially decreased the transfer of HIV-1 particles from dendritic cells to autologous T cells. These findings demonstrate partial inactivation of HIV infectivity and suggest that voiding urine after coitus could play a potential role in reducing the risk of HIV infection by both mechanically flushing out and neutralizing the infectivity of HIV-1 particles present in the genital tract."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit\u00e9 INSERM U, H\u00f4pital Paul Brousse, Villejuif, France."
          }
        ],
        "LastName": "Auvert",
        "ForeName": "Bertran",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Jenabian",
        "ForeName": "Mohammad-Ali",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Saidi",
        "ForeName": "H\u00e9la",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lissouba",
        "ForeName": "Pascale",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "B\u00e9lec",
        "ForeName": "Laurent",
        "Initials": "L"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Austria",
    "MedlineTA": "Arch Virol",
    "NlmUniqueID": "7506870",
    "ISSNLinking": "0304-8608"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "CXCR4 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, CCR5"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, CXCR4"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "urine"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "CD4-Positive T-Lymphocytes"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Dendritic Cells"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "prevention & control",
        "transmission",
        "urine",
        "virology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "In Vitro Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Receptors, CCR5"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Receptors, CXCR4"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Transcytosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Inactivation"
    }
  ]
}